203 related articles for article (PubMed ID: 34853163)
1. Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats.
Hassan HM; Cai Q; Liang X; Xin J; Ren K; Jiang J; Shi D; Lu Y; Li T; Shang Y; He L; Chen X; Sun S; Li P; Guo B; Chen J; Yang H; Hu W; Chen X; Li J
Life Sci Alliance; 2022 Mar; 5(3):. PubMed ID: 34853163
[TBL] [Abstract][Full Text] [Related]
2. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF.
Li J; Liang X; Jiang J; Yang L; Xin J; Shi D; Lu Y; Li J; Ren K; Hassan HM; Zhang J; Chen P; Yao H; Li J; Wu T; Jin L; Ye P; Li T; Zhang H; Sun S; Guo B; Zhou X; Cai Q; Chen J; Xu X; Huang J; Hao S; He J; Xin S; Wang D; Trebicka J; Chen X; Li J;
Gut; 2022 Jan; 71(1):163-175. PubMed ID: 33431576
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure.
Hassan HM; Liang X; Xin J; Lu Y; Cai Q; Shi D; Ren K; Li J; Chen Q; Li J; Li P; Guo B; Yang H; Luo J; Yao H; Zhou X; Hu W; Jiang J; Li J
BMC Med; 2024 Mar; 22(1):95. PubMed ID: 38439091
[TBL] [Abstract][Full Text] [Related]
4. Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure.
Wu W; Sun S; Wang Y; Zhao R; Ren H; Li Z; Zhao H; Zhang Y; Sheng J; Chen Z; Shi Y
Front Immunol; 2021; 12():620365. PubMed ID: 33717119
[TBL] [Abstract][Full Text] [Related]
5. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.
Bernsmeier C; Pop OT; Singanayagam A; Triantafyllou E; Patel VC; Weston CJ; Curbishley S; Sadiq F; Vergis N; Khamri W; Bernal W; Auzinger G; Heneghan M; Ma Y; Jassem W; Heaton ND; Adams DH; Quaglia A; Thursz MR; Wendon J; Antoniades CG
Gastroenterology; 2015 Mar; 148(3):603-615.e14. PubMed ID: 25479139
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure.
Liang X; Li P; Jiang J; Xin J; Luo J; Li J; Chen P; Ren K; Zhou Q; Guo B; Zhou X; Chen J; He L; Yang H; Hu W; Ma S; Li B; Chen X; Shi D; Li J;
JHEP Rep; 2023 Sep; 5(9):100848. PubMed ID: 37583946
[TBL] [Abstract][Full Text] [Related]
7. Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure.
Yang L; Zhen L; Li Z; Zhu S; Xu W; Luo Q; Peng L; Xie C
Front Microbiol; 2022; 13():1080484. PubMed ID: 36532504
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha.
Wang X; Xu H; Wang Y; Shen C; Ma L; Zhao C
Ann Hepatol; 2020; 19(2):214-221. PubMed ID: 31628069
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure.
Rueschenbaum S; Ciesek S; Queck A; Widera M; Schwarzkopf K; Brüne B; Welsch C; Wedemeyer H; Zeuzem S; Weigert A; Lange CM
Front Immunol; 2020; 11():534731. PubMed ID: 33574809
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.
Engelmann C; Sheikh M; Sharma S; Kondo T; Loeffler-Wirth H; Zheng YB; Novelli S; Hall A; Kerbert AJC; Macnaughtan J; Mookerjee R; Habtesion A; Davies N; Ali T; Gupta S; Andreola F; Jalan R
J Hepatol; 2020 Jul; 73(1):102-112. PubMed ID: 31987990
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure.
Peng B; Li H; Liu K; Zhang P; Zhuang Q; Li J; Yang M; Cheng K; Ming Y
J Transl Med; 2023 Jun; 21(1):419. PubMed ID: 37380987
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model.
Ni S; Li S; Yang N; Tang X; Zhang S; Hu D; Lu M
Mediators Inflamm; 2017; 2017():1390458. PubMed ID: 28194045
[No Abstract] [Full Text] [Related]
13. Inflammatory signature in acute-on-chronic liver failure includes increased expression of granulocyte genes ELANE, MPO and CD177.
Saha R; Pradhan SS; Shalimar ; Das P; Mishra P; Singh R; Sivaramakrishnan V; Acharya P
Sci Rep; 2021 Sep; 11(1):18849. PubMed ID: 34552111
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
[TBL] [Abstract][Full Text] [Related]
15. Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure.
Zhou Q; Ding W; Jiang L; Xin J; Wu T; Shi D; Jiang J; Cao H; Li L; Li J
Sci Rep; 2016 Feb; 6():20759. PubMed ID: 26861114
[TBL] [Abstract][Full Text] [Related]
16. Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats.
Li FF; Liu N; Liu W; Li M; Zhang F; Dong Z; Zhang JL; Sun H
Chin Med J (Engl); 2020 Jan; 133(2):198-204. PubMed ID: 31880746
[TBL] [Abstract][Full Text] [Related]
17. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
Monteiro S; Grandt J; Uschner FE; Kimer N; Madsen JL; Schierwagen R; Klein S; Welsch C; Schäfer L; Jansen C; Claria J; Alcaraz-Quiles J; Arroyo V; Moreau R; Fernandez J; Bendtsen F; Mehta G; Gluud LL; Møller S; Praktiknjo M; Trebicka J
Gut; 2021 Feb; 70(2):379-387. PubMed ID: 32241903
[TBL] [Abstract][Full Text] [Related]
18. Mitofusin2, a rising star in acute-on-chronic liver failure, triggers macroautophagy via the mTOR signalling pathway.
Xue R; Zhu X; Jia L; Wu J; Yang J; Zhu Y; Meng Q
J Cell Mol Med; 2019 Nov; 23(11):7810-7818. PubMed ID: 31557386
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity.
Korf H; du Plessis J; van Pelt J; De Groote S; Cassiman D; Verbeke L; Ghesquière B; Fendt SM; Bird MJ; Talebi A; Van Haele M; Feio-Azevedo R; Meelberghs L; Roskams T; Mookerjee RP; Mehta G; Jalan R; Gustot T; Laleman W; Nevens F; van der Merwe SW
Gut; 2019 Oct; 68(10):1872-1883. PubMed ID: 30580251
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
